Gastroenterology

How might a substance previously thought worth its weight in gold have transformed into something many medical institutions consider a key predictor of disease?

Earlier diagnosis and treatment can lead to better outcomes.

Pharmacist offers new evidence-based resource on how to improve microbiome with latest book.

It’s estimated that most Canadians with celiac disease don’t know they have it.

Glucagon-like peptide-1 receptor agonists, commonly used for diabetes and obesity management, are known to slow gastrointestinal motility.

Danish study found a 40% to 80% increased risk.

All of the following statements about the use of Rinvoq (upadacitinib) in inflammatory bowel disease are true, EXCEPT for . . .

It is the first oral Janus kinase (JAK) inhibitor indicated for acute treatment and maintenance therapy in both Crohn's disease and ulcerative colitis in adults.